Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Neuroma, Acoustic 1Edema 1Brain Neoplasms 1

Interventions

Radiosurgery 6Bevacizumab 5Cochlear Implants 4Gentamicins 3Everolimus 3Lapatinib 2tozuleristide 1neratinib 1icotinib 1gallium Ga 68 dotatate 1brigatinib 1Triamcinolone Acetonide 1Temozolomide 1Sufentanil 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Mn-PyC3A 1Microsurgery 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Losartan 1Head Movements 1HDAC-42 1Fluoresceins 1Fluorescein 1Exome 1Endostatins 1Endoscopes 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroma, Acoustic × Losartan × CNS × Clear all
NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Massachusetts General Hospital

Phase 2 Active not recruiting
30 enrolled
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡